Search results
Johnson & Johnson reports data from Phase II prostate cancer trial
Clinical Trials Arena via Yahoo Finance· 2 days agoJohnson & Johnson Innovative Medicine Solid Tumor Medical Affairs vice-president Luca Dezzani said:...
...Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across...
Digital Journal· 2 days ago“The... in Finland, add to the growing body of evidence supporting the potential of TULSA as a mainstream treatment for prostate disease,” said Arun Menawat ...
King Charles admits cancer diagnosis came as a ‘shock,’ gives treatment update
NY Post via Yahoo News· 7 days agoCharles was heard saying that he was feeling “well” and “not too bad” as he continues to receive...
Princess Beatrice gives rare update on Sarah Ferguson’s cancer diagnosis
The Independent via Yahoo News· 1 day agoCharles, 75, had been diagnosed with an undisclosed type of cancer after a routine procedure to...
‘Game-Changing’ Prostate Cancer Screening Trial Could Cut Deaths by 40%
Men's Health· 7 days agoprostate-specific antigen (PSA) blood tests to screen for the disease showed the method prevented...
Why Prince Harry Won't Meet With King Charles During Visit to the U.K.
E! News via Yahoo News· 10 hours agoPrince Harry won't spend any time with King Charles III while in the U.K. for the 10th anniversary...
Cancer scans delayed over supply issues - hospital
BBC via Yahoo News· 2 days agoHe was initially told by Churchill Hospital in Oxford to expect an appointment for a PET (positron emission tomography) scan within two weeks before a ...
King Charles, Kate Middleton's cancer battles make them more relatable to British public: experts
Fox News· 1 day agoCharles III has won over the hearts of many Britons as he faces his biggest battle yet. The reigning...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
The Journal Times· 5 days agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 10 hours agoIn more than 100 independent publications by urologists since then, the 4Kscore has ranked as the best-performing biomarker test for the assessment of...